Encompass Health Corp

Company Profile

Encompass Health Corp had its IPO on 1986-09-30 under the ticker symbol EHC.

The company operates in the Healthcare sector and Medical Care Facilities industry. Encompass Health Corp has a staff strength of 35,900 employees.

Stock update

Shares of Encompass Health Corp opened at $68.96 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $68.11 - $69.32, and closed at $68.32.

This is a -1.27% slip from the previous day's closing price.

A total volume of 613,614 shares were traded at the close of the day’s session.

In the last one week, shares of Encompass Health Corp have slipped by -3.76%.

Encompass Health Corp's Key Ratios

Encompass Health Corp has a market cap of $6.30 billion, indicating a price to book ratio of 4.6049 and a price to sales ratio of 1.0721.

In the last 12-months Encompass Health Corp’s revenue was $4.45 billion with a gross profit of $1.75 billion and an EBITDA of $906 million. The EBITDA ratio measures Encompass Health Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Encompass Health Corp’s operating margin was 14.75% while its return on assets stood at 6.46% with a return of equity of 17%.

In Q1, Encompass Health Corp’s quarterly earnings growth was a negative -0.1% while revenue growth was a positive 9.5%.

Encompass Health Corp’s PE and PEG Ratio

Forward PE

16.6667

Trailing PE

22.2908

PEG

Its diluted EPS in the last 12-months stands at $2.82 per share while it has a forward price to earnings multiple of 16.6667 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Encompass Health Corp’s profitability.

Encompass Health Corp stock is trading at a EV to sales ratio of 1.5848 and a EV to EBITDA ratio of 8.3347. Its price to sales ratio in the trailing 12-months stood at 1.0721.

Encompass Health Corp stock pays annual dividends of $0.73 per share, indicating a yield of 0.96% and a payout ratio of 18.07%.

Balance sheet and cash flow metrics

Total Assets

$5.75 billion

Total Liabilities

$592.10 million

Operating Cash Flow

$-104000000.00

Capital Expenditure

$96.60 million

Dividend Payout Ratio

18.07%

Encompass Health Corp ended 2024 with $5.75 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $5.75 billion while shareholder equity stood at $1.38 billion.

Encompass Health Corp ended 2024 with $87.00 million in deferred long-term liabilities, $592.10 million in other current liabilities, in common stock, $0 in retained earnings and $1.27 billion in goodwill. Its cash balance stood at $85.00 million and cash and short-term investments were $85.00 million. The company’s total short-term debt was $52,300,000 while long-term debt stood at $2.72 billion.

Encompass Health Corp’s total current assets stands at $761.70 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $514.50 million compared to accounts payable of $141.10 million and inventory worth $0.

In 2024, Encompass Health Corp's operating cash flow was $-104000000.00 while its capital expenditure stood at $96.60 million.

Comparatively, Encompass Health Corp paid $0.18 in dividends in 2024.

Other key metrics

Current Trading Price

$68.32

52-Week High

$66.44

52-Week Low

$41.5837

Analyst Target Price

$73.36

Encompass Health Corp stock is currently trading at $68.32 per share. It touched a 52-week high of $66.44 and a 52-week low of $66.44. Analysts tracking the stock have a 12-month average target price of $73.36.

Its 50-day moving average was $68.8 and 200-day moving average was $61.99 The short ratio stood at 3.01 indicating a short percent outstanding of 0%.

Around 179% of the company’s stock are held by insiders while 9971.8% are held by institutions.